Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

The new nanoparticles could improve melanoma treatment by working better than current options.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

A new delivery system makes Curcumin more effective and safer against viruses.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Some dibenzo compounds might help treat cancer with fewer side effects.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Five FDA-approved drugs may help block COVID-19 virus entry.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

DPCP is effective for treating severe alopecia areata, but relapse is common.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.